Meitheal Pharmaceuticals, Inc recalls Cetrorelix Acetate for Injection
- Recalling company
- Meitheal Pharmaceuticals, Inc
- Product
- Cetrorelix Acetate for Injection (Kit), 0.25 mg per vial, Single-Dose Kit, Rx Only, Mfd. for: Meitheal Pharmaceuticals, Chicago, IL NDC 71288-558-90.
- Reason
- Defective Delivery System: Missing or duplicated needles within the injection kit
- Classification
- Class II – may cause temporary or medically reversible health consequences
- Recall date
- Feb 9, 2026
- Reported
- Feb 18, 2026
- Distribution
- U.S. Nationwide
- Status
- Ongoing
- Quantity
- 16,477 kits
- Lot / codes
- Lot Q4E0112A, Exp.: 30 Apr 2027
- Company location
- Chicago, IL
- Recall type
- Voluntary: Firm initiated
- Recall number
- D-0340-2026
- Agency
- U.S. Food and Drug Administration (FDA)
View official FDA notice ↗ Search recall number D-0340-2026 in the FDA Enforcement Report. Also see FDA recall press releases.
If you use this product, check the lot, NDC or model number against the official notice and follow its instructions. Do not stop a prescribed medicine or remove a medical device without talking to your doctor or pharmacist. Report problems to FDA MedWatch. FoodRecallNow summarizes public FDA data and is not medical advice.